Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

S 731Session 2025-2026

What changed between versions

27 paragraphs changed+118 words added−21 removed

Highlighted text was added in the newer version. Struck-through text was removed.

South Carolina General Assembly 126th Session, 2025-2026

Bill 731

Download This Bill in Microsoft Word Format

Indicates Matter Stricken Indicates New Matter

(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)

S. 731

STATUS INFORMATION

General Bill Sponsors: Senator Kennedy Document Path: LC-0418SA26.docx

Introduced in the Senate on January 13, 2026 Currently residing in the Senate Committee on Labor, Commerce and Industry

HISTORY OF LEGISLATIVE ACTIONS

Date

Body

Action Description with journal page number

12/10/2025

Senate

Prefiled

12/10/2025

Senate

Referred to Committee on Labor, Commerce and Industry

1/13/2026

Senate

Introduced and read first time (Senate Journal-page 34)

1/13/2026

Senate

Referred to Committee on Labor, Commerce and Industry (Senate Journal-page 34)

View the latest legislative information at the website

VERSIONS OF THIS BILL

12/10/2025

A bill

12 unchanged paragraphs

TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY ADDING SECTION 39-1-100 SO AS TO PROVIDE THAT A COMPANY OR INDIVIDUAL MAY NOT SELL AN INDIVIDUAL'S GENETIC MATERIAL, TO PROVIDE WRITTEN CONSENT MUST BE OBTAINED THROUGH AN INDEPENDENT DOCUMENT, AND TO PROVIDE FOR PRIVATE RIGHTS OF ACTION.

Be it enacted by the General Assembly of the State of South Carolina:

SECTION 1. Chapter 1, Title 39 of the S.C. Code is amended by adding:

Section 39-1-100. (A)(1) A company or individual may not sell an individual's genetic material, regardless of how the genetic material was obtained, without prior written consent.

(2) For the purposes of this section, "genetic material" means the hereditary substance that stores and transmits a person's genetic information, primarily in the form of DNA or, in some cases, RNA.

(B) Written consent may be obtained only through an independent document. That independent document may address only the selling or sharing of genetic information and must provide the ability to opt-out of specific levels of sharing the genetic information. The independent document may not be included in a larger document and must be conspicuous.

(C) A company has no legal rights to an individual's genetic information or material. Only the individual may own his genetic information.

(D) A person or entity may bring a private right of action:

(1) based on a violation of this section or any regulations prescribed pursuant to this section to enjoin such violation;

(2) to recover for actual monetary loss from such a violation, or to receive five hundred dollars in damages for each violation, whichever is greater; or

(3) for both actions described in subitems (a) and (b).

SECTION 2. This act takes effect upon approval by the Governor.

----XX----

This web page was last updated on DecemberJanuary 1013, 20252026 at 021:2909 PM

Back to the full text